Hysterectomy. Postprocedural disorder of genitourinary system, unspecified
Conditions
Interventions
Intervention 1: Administration of bolus Mg-sulphate (50%) (50mg/kg) during 15 minutes, before the induction. Intervention 2: Administration of Mg-sulphate with dose of 50mg/kg (bolus) (during 15 minut
Treatment - Drugs
Administration of bolus Mg-sulphate (50%) (50mg/kg) during 15 minutes, before the induction.
Administration of Mg-sulphate with dose of 50mg/kg (bolus) (during 15 minutes) before the induction and then 15 mg/kg/hr continuously.
Sponsors
Vice Chancellor for Research, Guilan University of Medical Sciences-Rasht-Iran
Eligibility
Sex/Gender
Female
Age
35 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion Criteria:Age between 35-55; ASA I,II; No previous abdominal surgeries; systemic major cardiovascular diseases; musculoskeletal disorders; hepatic diseases; Calcium beta-blocker consumption; No previous renal insufficiency; nephropathy; myopathy; No allergy to Mg sulphate or other drugs; No drug abuse Exclusion criteria: Surgeries which will lasted more than 1 hour
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain severity. Timepoint: 1-6-18-24 hours. Method of measurement: Visual Analog Scale(VAS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse drug reaction. Timepoint: 1-6-18-24 hours. Method of measurement: History.;Pethidine consumption. Timepoint: 1-6-18-24 hours. Method of measurement: Whole pethidine dose usage. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Katayoun Haryalchi
Guilan University of Medical Sciences
Outcome results
None listed